封面
市场调查报告书
商品编码
1771504

美国肾臟保存市场规模、份额、趋势分析报告:按保存解决方案、技术、捐赠者类型、最终用途、细分市场预测,2025-2030 年

U.S. Kidney Preservation Market Size, Share & Trends Analysis Report By Preservation Solution (University of Wisconsin Solution, Celsior Solution), By Technique (Static Cold Storage), By Donor Type, By End Use, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10个工作天内

价格

美国肾臟保存市场的趋势:

美国肾臟保存市场规模预计在2024年达到2,120万美元,预计2025年至2030年的复合年增长率为6.97%。市场成长的驱动因素包括末期肾功能衰竭(ESRD)以及糖尿病、高血压等慢性疾病的盛行率上升。肾臟移植需求的不断增长也推动了市场的成长。常温机械灌注等保存技术的进步提高了器官在运输和储存过程中的存活率。政府支持器官捐赠计画的措施也进一步推动了市场的发展。

美国肾臟保存市场扩张的主要驱动力是死者捐赠移植数量的持续增长,这增加了对可靠保存解决方案的需求。例如,根据器官取得与移植网络 (OPTN) 的数据,美国死者捐赠移植数量预计将从 2014 年的 12,279 例增加到 2024 年的 22,074 例。最近的趋势表明,阿片类药物相关死亡和捐赠者接受标准的扩大导致死者捐赠数量增加。由于器官获取组织 (OPO) 优先从具有不同生理特征的捐赠者(包括患有急性肾损伤 (AKI) 和併发症的捐赠者)获取肾臟,因此依赖先进的保存技术对于优化移植结果至关重要。此外,UNOS 于 2021 年转向基于距离的肾臟分配政策,扩大了器官分配的地理半径,进一步强调了延长保存技术的重要性。

同样,美国的肾臟移植数量也在大幅增加,预计在预测期内这种趋势仍将持续,从而增加对先进肾臟保存解决方案的需求。

此外,美国肾臟保存市场的成长也受到政府和组织旨在提高肾臟捐赠率的倡议的推动。诸如「推进美国肾臟健康倡议」等联邦计画以及医疗保险和医疗补助服务中心 (CMS) 的政策改革,均优先考虑扩大器官移植的可及性,激励奖励获取组织 (OPO) 增加可行肾臟的获取和利用。

2024年,生命礼物捐赠计画(Gift of Life Donor Program)协调了947例肾臟移植,位居美国器官采购机构之首,并连续九年保持领先地位。这家总部位于费城的机构正值成立50週年,迄今促成超过21,000例肾臟移植。预计各机构的此类努力将进一步增加美国的肾臟捐赠数量,从而在预测期内推动对器官保存解决方案的需求。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国肾臟保存市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 肾臟保存市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国肾臟保存市场:保存解决方案的估计和趋势分析

  • 细分仪表板
  • 美国肾臟保存市场趋势分析(Preservation Solution)
  • 2018-2030 年美国肾臟保存市场规模及趋势分析(依保存解决方案)
  • 威斯康辛大学(UW)解决方案
  • 组胺酸-色胺酸-酮戊二酸(HTK)溶液
  • Celsior 溶液
  • 高渗透压柠檬酸腺嘌呤(HC-A)溶液
  • 豪尔赫洛佩兹研究所 (IGL-1) 解决方案
  • 其他的

第五章美国肾臟保存市场:技术评估与趋势分析

  • 细分仪表板
  • 美国肾臟保存市场趋势分析(按技术)
  • 2018-2030 年美国肾臟保存市场规模及趋势分析(依技术)
  • 静态冷藏保管
  • 低温机械灌注
  • 常温机械灌注

第六章美国肾臟保存市场:按捐赠者类型进行的估计和趋势分析

  • 细分仪表板
  • 美国肾臟保存市场(按捐赠者类型)趋势分析
  • 2018-2030 年美国肾臟保存市场规模及趋势分析(依捐赠者类型)
  • 标准捐赠者(SCD)
  • 扩展标准捐助者 (ECD)
  • 脑死(DBD)后器官捐赠
  • 循环死亡(DCD)后的器官捐赠
  • 活体捐赠者

第七章美国肾臟保存市场:依最终用途的估计和趋势分析

  • 细分仪表板
  • 美国肾臟保存市场最终用途趋势分析
  • 2018-2030 年美国肾臟保存市场规模及趋势分析(依最终用途)
  • 移植中心/医院
  • 器官捐赠组织(OPO)
  • 其他的

第八章 竞争态势

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • TransMedics Inc.
    • XVIVO
    • Bridge to Life Ltd.
    • Paragonix Technologies Inc.
    • OrganOx Limited
    • Organ Recovery Systems
    • Institut Georges Lopez(IGL)
    • Preservation Solutions, Inc.
    • Global Transplant Solutions
    • Essential Pharmaceuticals LLC
Product Code: GVR-4-68040-606-3

U.S. Kidney Preservation Market Trends:

The U.S. kidney preservation market size was estimated at USD 21.2 million in 2024 and is expected to grow at a CAGR of 6.97% from 2025 to 2030. The market growth is driven by several factors, including the rising incidence of end-stage renal disease (ESRD) and chronic conditions such as diabetes and hypertension. The increasing demand for kidney transplants also fuels market growth. Advances in preservation technologies, such as normothermic machine perfusion, enhance organ viability during transportation and storage. Government initiatives supporting organ donation programs further boost the market.

A major driver of the U.S. kidney preservation market's expansion is the consistent rise in deceased donor transplants, which has led to a greater need for reliable preservation solutions. For instance, according to the Organ Procurement & Transplantation Network (OPTN), the deceased donor transplants in the U.S. increased from 12,279 in 2014 to 22,074 in 2024. According to recent trends, the number of deceased donors has increased due to a combination of opioid-related deaths and expanded donor acceptance criteria. As organ procurement organizations (OPOs) prioritize the recovery of kidneys from donors with varying physiological profiles, including those with AKI or comorbidities, reliance on advanced preservation becomes critical to optimize transplant outcomes. Additionally, the 2021 shift to a distance-based kidney allocation policy by UNOS has increased the geographic radius of organ distribution, further intensifying the importance of extended preservation techniques.

Similarly, the number of kidney transplants in the U.S. is witnessing a significant surge, which is expected to continue over the forecast period, thereby increasing the demand for advanced kidney preservation solutions.

Moreover, the growth of the U.S. kidney preservation market is also driven by a rise in government and organizational initiatives aimed at boosting kidney donation rates. Federal programs such as the Advancing American Kidney Health Initiative and policy reforms by the Centers for Medicare & Medicaid Services (CMS) have prioritized expanding access to transplantation by incentivizing organ procurement organizations (OPOs) to increase recovery and utilization of viable kidneys.

In 2024, the Gift of Life Donor Program led U.S. organ procurement organizations by coordinating 947 kidney transplants, marking its ninth consecutive year at the forefront. Celebrating its 50th anniversary, the Philadelphia-based organization has facilitated over 21,000 kidney transplants. Such initiatives by various organizations are further expected to increase the number of kidney donations in the country, thereby driving demand for preservation solutions over the forecast period.

U.S. Kidney Preservation Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. kidney preservation market report based on preservation solution, technique, donor type, and end use.

  • Preservation Solution Outlook (Revenue, USD Million, 2018 - 2030)
  • University of Wisconsin (UW)
  • Histidine-Tryptophan-Ketoglutarate (HTK) Solution
  • Celsior Solution
  • Hypertonic Citrate Adenine (HC-A) Solution
  • Institute Georges Lopez (IGL-1) Solution
  • Others
  • Technique Outlook (Revenue, USD Million, 2018 - 2030)
  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion
  • Other
  • Donor Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Standard Criteria Donor (SCD)
  • Expanded Criteria Donor (ECD)
  • Donation after Brain Death (DBD)
  • Donation after Circulatory Death (DCD)
  • Living Donor
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Transplant Centers / Hospitals
  • Organ Procurement Organizations (OPOs)
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Preservation Solution Segment
    • 1.2.2. Technique Segment
    • 1.2.3. Donor Type Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Kidney Preservation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of kidney diseases
      • 3.2.1.2. Growing kidney donations and transplants
      • 3.2.1.3. Growing geriatric population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of kidney transplantation
  • 3.3. Kidney Preservation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Kidney Preservation Market: Preservation Solution Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Kidney Preservation Market Preservation Solution Movement Analysis
  • 4.3. U.S. Kidney Preservation Market Size & Trend Analysis, by Preservation Solution, 2018 to 2030 (USD Million)
  • 4.4. University of Wisconsin (UW)
    • 4.4.1. University of Wisconsin (UW) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Histidine-Tryptophan-Ketoglutarate (HTK) Solution
    • 4.5.1. Histidine-Tryptophan-Ketoglutarate (HTK) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Celsior Solution
    • 4.6.1. Celsior Solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Hypertonic Citrate Adenine (HC-A) Solution
    • 4.7.1. Hypertonic Citrate Adenine (HC-A) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Institute Georges Lopez (IGL-1) Solution
    • 4.8.1. Institute Georges Lopez (IGL-1) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Kidney Preservation Market: Technique Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Kidney Preservation Market Technique Movement Analysis
  • 5.3. U.S. Kidney Preservation Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
  • 5.4. Static Cold Storage
    • 5.4.1. Static cold storage market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Hypothermic Machine Perfusion
    • 5.5.1. Hypothermic machine perfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Normothermic Machine Perfusion
    • 5.6.1. Normothermic machine perfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Kidney Preservation Market: Donor Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Kidney Preservation Market Donor Type Movement Analysis
  • 6.3. U.S. Kidney Preservation Market Size & Trend Analysis, by Donor Type, 2018 to 2030 (USD Million)
  • 6.4. Standard Criteria Donor (SCD)
    • 6.4.1. Standard Criteria Donor (SCD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Expanded Criteria Donor (ECD)
    • 6.5.1. Expanded Criteria Donor (ECD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Donation after Brain Death (DBD)
    • 6.6.1. Donation after Brain Death (DBD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Donation after Circulatory Death (DCD)
    • 6.7.1. Donation after Circulatory Death (DCD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. Living Donor
    • 6.8.1. Living donor market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Kidney Preservation Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Kidney Preservation Market End Use Movement Analysis
  • 7.3. U.S. Kidney Preservation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Transplant Centers / Hospitals
    • 7.4.1. Transplant centers / Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Organ Procurement Organizations (OPOs)
    • 7.5.1. Organ Procurement Organizations (OPOs) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. TransMedics Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. XVIVO
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Bridge to Life Ltd.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Paragonix Technologies Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. OrganOx Limited
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Organ Recovery Systems
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Institut Georges Lopez (IGL)
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Preservation Solutions, Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Global Transplant Solutions
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Essential Pharmaceuticals LLC
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. kidney preservation market by preservation solution, 2018 - 2030 (USD Million)
  • Table 4 U.S. kidney preservation market by technique, 2018 - 2030 (USD Million)
  • Table 5 U.S kidney preservation market by donor type, 2018 - 2030 (USD Million)
  • Table 6 U.S kidney preservation market by end use, 2018 - 2030 (USD Million)
  • Table 7 Participant's overview
  • Table 8 Financial performance
  • Table 9 Key companies undergoing expansions
  • Table 10 Key companies undergoing acquisitions
  • Table 11 Key companies undergoing collaborations
  • Table 12 Key companies launching new products
  • Table 13 Key companies undergoing partnerships
  • Table 14 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. kidney preservation market: Market outlook
  • Fig. 5 U.S. kidney preservation market: Segment outlook
  • Fig. 6 U.S. kidney preservation market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. kidney preservation market driver impact
  • Fig. 9 U.S. kidney preservation market restraint impact
  • Fig. 10 U.S. kidney preservation market, solution outlook key takeaways (USD Million)
  • Fig. 11 U.S. kidney preservation market solution movement analysis 2024 & 2030 (USD Million)
  • Fig. 12 University of Wisconsin (UW) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Histidine-Tryptophan-Ketoglutarate (HTK) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Celsior solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Hypertonic citrate adenine (HC-A) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Institut Georges Lopez-1 (IGL-1) solution market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 U.S. kidney preservation market, technique outlook key takeaways (USD Million)
  • Fig. 19 U.S. kidney preservation market technique movement analysis 2024 & 2030 (USD Million)
  • Fig. 20 Static cold storage market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Hypothermic machine perfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Normothermic machine perfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. kidney preservation market, donor type outlook key takeaways (USD Million)
  • Fig. 24 U.S. kidney preservation market donor type movement analysis 2024 & 2030 (USD Million)
  • Fig. 25 Standard Criteria Donor (SCD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Expanded Criteria Donor (ECD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Donation after Brain Death (DBD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Donation after Circulatory Death (DCD) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Living donor market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. kidney preservation market, end use outlook key takeaways (USD Million)
  • Fig. 31 U.S. kidney preservation market end use movement analysis 2024 & 2030 (USD Million)
  • Fig. 32 Transplant centers / hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Organ Procurement Organizations (OPOs) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Heat map analysis
  • Fig. 36 Market participant categorization
  • Fig. 37 U.S. kidney preservation market share analysis, 2024
  • Fig. 38 Strategy framework